Regulators studying Comerica tech issue that led to trust client account errors: WSJ
An upgrade of Comerica Inc.'s (CMA) technology platform inadvertently caused millions of dollars in account shortfalls in its wealth management trust unit, The Wall Street Journal reported on Wednesday. The Office of the Comptroller of the Currency is studying the technology platform change at Comerica that triggered failures on transactions for trust clients, the newspaper reported. Client withdrawals from trust assets administered by Comerica ran into trouble, leaving a hole in the bank's funds, the report said. Greg Carr, executive vice president of wealth management at Comerica, told The Wall Street Journal that the bank has been working "swiftly" to remediate the issues. So far, the problems have caused the bank to write off $500,000, the article said. Comerica stock was up 1% in recent trading. The bank has reported $175 billion in assets under its administration in its trust unit as of Sept. 30.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-06-23 1145ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
After Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
Is ServiceNow Stock a Buy After Earnings and Its Investor Day?
-
3 Stocks to Buy and 3 Stocks to Sell After Earnings
-
Markets Brief: Is It Really a Surprising Quarter for Earnings?
-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Occidental Earnings: CrownRock Transaction Should Still Close, but Not Until the Third Quarter
-
After Earnings, Is Apple Stock a Buy, a Sell, or Fairly Valued?
-
Uber Earnings: Network Effect Continues to Drive Profitable Growth for Uber
-
Undervalued by 28%, This Stock Is a Buy for Patient Investors
-
10 Best Growth Stocks to Buy for the Long Term
-
The Best Technology Stocks to Buy
-
After Earnings, Is Coke Stock a Buy, a Sell, or Fairly Valued?
-
Disney Earnings: Improved Streaming Results Come at the Expense of Continued Linear Weakness